These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 34598007)
21. Diagnostic accuracy of technetium-99m-pertechnetate scintigraphy with lemon juice stimulation to evaluate Warthin's tumor. Murata Y; Yamada I; Umehara I; Okada N; Shibuya H J Nucl Med; 1998 Jan; 39(1):43-6. PubMed ID: 9443737 [TBL] [Abstract][Full Text] [Related]
22. Multi-parametric MR imaging using pseudo-continuous arterial-spin labeling and diffusion-weighted MR imaging in differentiating subtypes of parotid tumors. Razek AAKA Magn Reson Imaging; 2019 Nov; 63():55-59. PubMed ID: 31422165 [TBL] [Abstract][Full Text] [Related]
23. Usefulness of heavily T(2) weighted magnetic resonance images for the differential diagnosis of parotid tumours. Sakamoto M; Sasano T; Higano S; Takahashi S; Iikubo M; Kakehata S Dentomaxillofac Radiol; 2003 Sep; 32(5):295-9. PubMed ID: 14709603 [TBL] [Abstract][Full Text] [Related]
24. Interest of diffusion-weighted and gadolinium-enhanced dynamic MR sequences for the diagnosis of parotid gland tumors. Lechner Goyault J; Riehm S; Neuville A; Gentine A; Veillon F J Neuroradiol; 2011 May; 38(2):77-89. PubMed ID: 20542568 [TBL] [Abstract][Full Text] [Related]
25. Value of T2-weighted-based radiomics model in distinguishing Warthin tumor from pleomorphic adenoma of the parotid. Hu Z; Guo J; Feng J; Huang Y; Xu H; Zhou Q Eur Radiol; 2023 Jun; 33(6):4453-4463. PubMed ID: 36502461 [TBL] [Abstract][Full Text] [Related]
26. [Value of manifestations of magnetic resonance imaging (MRI) in diagnosis of parotid tumors and their pathological bases]. Yuan JP; Liang BL; Xie BK; Song ZC; Zhong JL Ai Zheng; 2003 May; 22(5):514-9. PubMed ID: 12753715 [TBL] [Abstract][Full Text] [Related]
27. [Performance of the magnetic resonance imaging in parotid gland tumor histopathology]. Masmoudi M; Hasnaoui M; Guizani R; Lahmar R; Jerbi S; Mighri K Pan Afr Med J; 2021; 39():10. PubMed ID: 34178238 [TBL] [Abstract][Full Text] [Related]
28. Pleomorphic adenoma and adenolymphoma in ultrasonography. Zajkowski P; Jakubowski W; Białek EJ; Wysocki M; Osmólski A; Serafin-Król M Eur J Ultrasound; 2000 Sep; 12(1):23-9. PubMed ID: 10996767 [TBL] [Abstract][Full Text] [Related]
29. Differential diagnosis of parotid gland tumours: which magnetic resonance findings should be taken in account? Tartaglione T; Botto A; Sciandra M; Gaudino S; Danieli L; Parrilla C; Paludetti G; Colosimo C Acta Otorhinolaryngol Ital; 2015 Oct; 35(5):314-20. PubMed ID: 26824912 [TBL] [Abstract][Full Text] [Related]
30. Gray scale and Doppler ultrasonography of the benign tumors of parotid gland (pleomorphic adenoma and Warthin's tumor). Pictorial essay. Fodor D; Pop S; Maniu A; Cosgaria M Med Ultrason; 2010 Sep; 12(3):238-44. PubMed ID: 21203603 [TBL] [Abstract][Full Text] [Related]
31. Clinical and demographic data improve diagnostic accuracy of dynamic contrast-enhanced and diffusion-weighted MRI in differential diagnostics of parotid gland tumors. Mikaszewski B; Markiet K; Smugała A; Stodulski D; Szurowska E; Stankiewicz C Oral Oncol; 2020 Dec; 111():104932. PubMed ID: 32739792 [TBL] [Abstract][Full Text] [Related]
32. Differentiating parotid tumors by quantitative signal intensity evaluation on MR imaging. Matsusue E; Fujihara Y; Matsuda E; Tokuyasu Y; Nakamoto S; Nakamura K; Ogawa T Clin Imaging; 2017; 46():37-43. PubMed ID: 28704680 [TBL] [Abstract][Full Text] [Related]
33. Assessment of dynamic MRI of Warthin's tumors arising as multiple lesions in the parotid glands. Hisatomi M; Asaumi J; Konouchi H; Yanagi Y; Matsuzaki H; Kishi K Oral Oncol; 2002 Jun; 38(4):369-72. PubMed ID: 12076701 [TBL] [Abstract][Full Text] [Related]
34. Radiomic model for differentiating parotid pleomorphic adenoma from parotid adenolymphoma based on MRI images. Song LL; Chen SJ; Chen W; Shi Z; Wang XD; Song LN; Chen DS BMC Med Imaging; 2021 Mar; 21(1):54. PubMed ID: 33743615 [TBL] [Abstract][Full Text] [Related]
35. MRI criteria for the diagnosis of pleomorphic adenoma: a validation study. Zaghi S; Hendizadeh L; Hung T; Farahvar S; Abemayor E; Sepahdari AR Am J Otolaryngol; 2014; 35(6):713-8. PubMed ID: 25128908 [TBL] [Abstract][Full Text] [Related]
36. Bilateral and multifocal Warthin's tumors of parotid glands: PET/CT imaging. Nguyen VX; Nguyen BD; Ram PC Clin Nucl Med; 2012 Feb; 37(2):175-7. PubMed ID: 22228345 [TBL] [Abstract][Full Text] [Related]
37. Development and validation of an MRI-based radiomics nomogram for distinguishing Warthin's tumour from pleomorphic adenomas of the parotid gland. Zheng YM; Chen J; Xu Q; Zhao WH; Wang XF; Yuan MG; Liu ZJ; Wu ZJ; Dong C Dentomaxillofac Radiol; 2021 Oct; 50(7):20210023. PubMed ID: 33950705 [TBL] [Abstract][Full Text] [Related]
38. Capsule of parotid gland tumor: evaluation by 3.0 T magnetic resonance imaging using surface coils. Ishibashi M; Fujii S; Kawamoto K; Nishihara K; Matsusue E; Kodani K; Kaminou T; Ogawa T Acta Radiol; 2010 Dec; 51(10):1103-10. PubMed ID: 20883183 [TBL] [Abstract][Full Text] [Related]
39. Quantitative dynamic contrast-enhanced MRI and readout segmentation of long variable echo-trains diffusion-weighted imaging in differentiating parotid gland tumors. Huang N; Xiao Z; Chen Y; She D; Guo W; Yang X; Chen Q; Cao D; Chen T Neuroradiology; 2021 Oct; 63(10):1709-1719. PubMed ID: 34241661 [TBL] [Abstract][Full Text] [Related]
40. Characterization of parotid gland tumors using diffusion-relaxation correlation spectrum imaging: a preliminary study. Chen W; Geng D; Xu XQ; Hu WT; Dai YM; Wu FY; Zhu LN Clin Radiol; 2024 Jun; 79(6):e878-e884. PubMed ID: 38582630 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]